Perbak Capital Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$613K	Buy	+1,167	New	+$613K	0.14%	153
2024 Q3	–	Sell	-650	Closed	-$683K	–	51
2024 Q2	$683K	Buy	+650	New	+$683K	0.2%	54